Private Access

What Private Access does

Private Access, Inc. is a privately-held health technology company headquartered in Irvine, California that develops the PrivateAccess™ platform, a consumer-centric system enabling patients and families to grant granular, conditional access to their personal health information (including electronic health records, genomic data, and patient-reported data) to specified researchers, providers, and institutions. The platform comprises four integrated modules—Data Capture, eConsent, Genomic Data, and RecruitSource® (a web-based clinical trial subject search engine)—and incorporates blockchain technology with smart contracts to enable a consented data-sharing economy across hospitals, disease advocacy organizations, blood banks, and genomic data banks. The company holds seven issued US patents with priority dates as early as 1997, covering granular access controls and privacy-assured database search technology.

The company monetizes through licensing of the PrivateAccess™ platform to healthcare institutions and recurring subscription revenue from its eConsent solutions, distributed via direct integration into existing healthcare data capture systems. Its go-to-market is enterprise field sales targeting hospitals, academic research institutions, and disease advocacy organizations; named customers and partners include Massachusetts General Hospital (via a PCORnet-funded study), Children's Hospital of Philadelphia, the United Mitochondrial Disease Foundation, Illumina, and Genetic Alliance (which connects the platform to over 1,200 non-profit disease advocacy groups). The company operates as an 11-50 employee private corporation with no disclosed funding rounds, parent company, or management team in the source material.

The product surface addresses a well-defined problem: clinical trial patient recruitment is characterized in source material as taking weeks, months, or years, against a stated market demand for 19.8 million research subjects, while 93% of US consumers reportedly want control over access to their personal information. Private Access' positioning is to collapse recruitment timelines into minutes via consent-mediated search, while embedding regulatory-compliant audit trails. The business model is asset-light software with patent-protected differentiated technology, though post-2017 commercial momentum is not documented in the available data.

Name

Private Access

Legal name

Private Access, Inc.

Website

https://privateaccess.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Private Access is an Irvine, CA-based health technology company that provides a patented privacy and eConsent platform enabling patients to control access to their health data for clinical research, serving hospitals, research institutions, and disease advocacy organizations.

Ownership category

akta.pro rank

Product category

Healthcare Privacy & Consent Software

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Consent, Privacy Management & Patient Identity (CIAM/Consent) (HLACAJAL)

akta.pro secondary industries

Patient Intake, Digital Registration & eForms (HLACAEAF), Patient-Mediated Exchange & Personal Health Data Access (Blue Button, SMART on FHIR) (HLACABAN), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)

Keywords

• Electronic consent software
• Health data privacy
• Patient recruitment platform
• Clinical trial matching
• Consent management

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Technology Platform Licensing: Licensing of the PrivateAccess™ platform to healthcare institutions, research organizations, and hospitals for patient data management and consent processing.
2. eConsent Solution: Electronic consent management solutions integrated into existing healthcare data systems, enabling institutions to move from paper processes to digital eConsent.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Private Access designs and develops a consumer-centric healthcare data platform (PrivateAccess™) that enables patients and families to grant granular, audited access to portions of their electronic health records, genomic data, and patient-reported survey data to specific researchers and institutions. The platform delivers integrated eConsent workflows, privacy-assured database search for researchers (RecruitSource®), and blockchain/smart-contract-based data sharing capabilities, replacing paper-based consent and recruitment with mobile, auditable digital workflows.

Product overview

Private Access offers a consumer-centric technology platform called PrivateAccess™ that permits patients and their families to control to whom and for what purposes they grant access to their personal health information. The platform consists of multiple integrated modules: Data Capture enables easy-to-understand clinical trial information sharing; eConsent provides integrated electronic consent workflows with audit trails; Genomic Data allows participants to share specific elements of their genomic sequence while maintaining privacy controls; and Research (RecruitSource®) provides a search engine for researchers to find clinical trial subjects. The platform also incorporates blockchain technology and smart contracts to establish a data sharing economy for health data holders.

Differentiator

Problem solved

Functional benefit

Products and services

• PrivateAccess™ Platform Consumer-centric foundational technology platform that allows individual users to grant 'private access' to all or portions of their personal information to specific people or groups, and/or under specific circumstances or conditions. Used by healthcare institutions and research organizations to enable consented patient data sharing.
• Data Capture with Private Access Module that provides patients with clear and easy-to-understand clinical trial information so they can make informed decisions about participating in research trials or studies, and offers sites tools to gain insight into patient responses.
• eConsent with Private Access Integrated electronic consent module that enables patients to easily request that their healthcare providers supply EHR data, creating instant, compliant access for researchers with full audit trails.
• Genomic Data with Private Access Module that allows participants to share specific elements of their genomic sequence with researchers, while controlling which genes/components are shared and whether their name and contact information is disclosed, protecting privacy while enabling genomic research.
• Research with Private Access (RecruitSource®) Web-based search engine (RecruitSource®) that lets researchers find subjects for clinical trials in minutes using a privacy-assured process with full audit trails, matching patients to appropriate clinical trials.

Quantifiable outcome

• Clinical trial subject matching reduced from weeks/months/years to minutes
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Children's Hospital of Philadelphia (CHOP)coreStrategic or Co-development Partner · 2 November 2017Children's Hospital of Philadelphia (CHOP), and United Mitochondrial Disease Foundation (UMDF), have teamed up to help save lives by using Private Access tools to obtain proper eConsent for the reclaiming and sharing of clinical data with researchers, so that better medications can be developed faster for those living with Mitochondrial disorders.
• United Mitochondrial Disease Foundation (UMDF)coreStrategic or Co-development Partner · 2 November 2017Partnership with CHOP to use Private Access tools for obtaining proper eConsent for the reclaiming and sharing of clinical data with researchers, so that better medications can be developed faster for those living with Mitochondrial disorders.
• Massachusetts General HospitalcoreStrategic or Co-development Partner · 10 June 2017Private Access recently launched integrated data collection and eConsent systems for a Massachusetts General Hospital study funded by PCORnet. The study will move from traditional paper processes for assessment, disclosure, and consent to participate, to a more rapid mobile eConsent process.
• Genetic AlliancecoreStrategic or Co-development Partner · 15 January 2017Private Access has been working with Genetic Alliance for over a decade to create systems to start capturing patient reported data from over 1,200 non-profit disease advocacy groups in hopes of providing more data to researchers to speed up treatments for all conditions.
• IlluminacoreStrategic or Co-development Partner · 25 August 2016Private Access and Illumina worked together on revolutionary genomic sequencing tools to enable people to control what parts of their genomic sequence they wish to share with researchers to help speed up drug trials, saving time, money and lives.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Antidote (Trial Library): Clinical trial matching and patient recruitment platform that pairs patients to trials using structured eligibility; comparable to Private Access's RecruitSource for connecting researchers to consented patient populations.
• HealthVerity: Privacy-secured health data exchange and identity resolution platform serving life sciences, government, and payers; offers directly overlapping capabilities around consent, governance, and researcher access to patient data at scale.
• Ciitizen (acquired by Invitae): Patient-mediated health data platform that empowers patients to aggregate and share their medical records with researchers and providers; directly comparable consumer-centric privacy/consent model targeting the same research data supply chain.
• Datavant: Health data connectivity and privacy-preserving linking platform that enables controlled sharing of patient-level health data across organizations; targets the same patient-data-sharing-for-research value proposition with comparable de-identification and consent workflows.

Broad incumbents

• Veeva Systems: Life sciences cloud platform with Vault eConsent and CTMS products that handle electronic consent and clinical trial operations at enterprise pharma scale; competes for the same research organization and sponsor budget allocations.
• IQVIA: Largest CRO and health data analytics company offering eConsent, site solutions, and patient recruitment; broadest incumbent competing for the same research workflow spend, though typically serving much larger pharma customers.
• Medidata Solutions: Enterprise clinical trial technology suite (now part of Dassault Systèmes) including eConsent and patient recruitment modules; broader portfolio competing for the same clinical-research customer spend as Private Access's Research and eConsent modules.
• Cerner Enviza (Oracle Health): EHR-embedded consent, de-identification, and data exchange tooling inside one of the largest hospital information systems; competes with Private Access on consent and patient-mediated data sharing from inside hospital IT infrastructure.

Emerging players

• Deep 6 AI: AI-powered clinical trial patient recruitment and cohort-building platform that mines EHR data to match patients to research; intersects with Private Access on speeding researcher access to eligible patients.
• Seqster: Patient-controlled health data aggregation platform combining EHR, DNA, and wearables under a single patient consent layer; comparable consumer-centric, longitudinal health-data-sharing model for research and clinical use.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Private Access